GLRA
IBB icon

Gerald L. Ray & Associates’s iShares Biotechnology ETF IBB Stock Holding History

Gerald L. Ray & Associates’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		$4.86M Sell
43,731
-504
-1% -$53.9K 0.61% 42
2017
Q2 		$4.57M Buy
44,235
+1,152
+3% +$113K 0.59% 42
2017
Q1 		$4.21M Buy
43,083
+4,347
+11% +$416K 0.58% 45
2016
Q4 		$3.43M Buy
38,736
+1,890
+5% +$172K 0.5% 51
2016
Q3 		$3.56M Buy
36,846
+2,304
+7% +$219K 0.53% 49
2016
Q2 		$2.96M Buy
34,542
+2,886
+9% +$259K 0.47% 57
2016
Q1 		$2.75M Buy
31,656
+7,431
+31% +$665K 0.45% 55
2015
Q4 		$2.73M Sell
24,225
-60
-0.2% -$6.51K 0.43% 56
2015
Q3 		$2.46M Sell
24,285
-675
-3% -$81K 0.41% 63
2015
Q2 		$3.07M Sell
24,960
-90
-0.4% -$10.8K 0.47% 56
2015
Q1 		$2.87M Sell
25,050
-45
-0.2% -$4.96K 0.43% 58
2014
Q4 		$2.54M Sell
25,095
-51
-0.2% -$4.96K 0.39% 63
2014
Q3 		$2.29M Buy
25,146
+75
+0.3% +$6.58K 0.37% 72
2014
Q2 		$2.15M Buy
25,071
+6,231
+33% +$491K 0.37% 74
2014
Q1 		$1.49M Buy
18,840
+1,035
+6% +$86.2K 0.27% 90
2013
Q4 		$1.35M Sell
17,805
-330
-2% -$23.4K 0.25% 89
2013
Q3 		$1.27M Sell
18,135
-150
-0.8% -$9.83K 0.26% 90
2013
Q2 		$1.06M Buy
+18,285
New +$1.06M 0.24% 97

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
CM
Churchill Management Los Angeles, California $9.21B AUM 19.91% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Gerald L. Ray & Associates's IBB Position: Q3 2017 in Review

Gerald L. Ray & Associates reduced its iShares Biotechnology ETF (IBB) stake by 1.1% in Q3 2017, selling an estimated $53.9K and leaving 43,731 shares worth $4.86M. The position accounts for 0.61% of the portfolio, ranked #42.

Gerald L. Ray & Associates first reported a position in IBB in Q2 2013 and has held it in 18 quarters since. 583 funds tracked by Wall St. Rank hold IBB as of Q3 2017.

  • Gerald L. Ray & Associates held 43,731 shares of iShares Biotechnology ETF worth $4.86M as of Q3 2017.
  • Gerald L. Ray & Associates sold 504 iShares Biotechnology ETF shares in Q3 2017, an estimated $53.9K.
  • iShares Biotechnology ETF made up 0.61% of Gerald L. Ray & Associates's portfolio in Q3 2017, its #42 holding.
  • Gerald L. Ray & Associates first reported a position in iShares Biotechnology ETF in Q2 2013 and has held it in 18 quarters since.
  • 583 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2017.

Based on Gerald L. Ray & Associates's 13F filing for Q3 2017, filed 31 Oct 2017.